At a glance
- Originator Mercian; Nonindustrial source
- Class Cytostatic antibiotics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 21 Feb 2000 No-Development-Reported for Cancer in Japan (Unknown route)
- 12 Mar 1997 New profile
- 12 Mar 1997 Preclinical development for Cancer in Japan (Unknown route)